bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
4.970
-0.010 (-0.20%)
At close: May 15, 2025, 4:00 PM
4.980
+0.010 (0.20%)
After-hours: May 15, 2025, 7:53 PM EDT
bluebird bio Stock Forecast
BLUE's stock price has decreased by -76.78% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for bluebird bio stock ranges from a low of $5.00 to a high of $120. The average analyst price target of $44.6 forecasts a 797.38% increase in the stock price over the next year.
Price Target: $44.60 (+797.38%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 31, 2025.
Analyst Ratings
The average analyst rating for bluebird bio stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 6 | 6 | 6 | 5 | 5 | 5 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $40 → $8 | Buy | Maintains | $40 → $8 | +60.97% | Mar 31, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $40 → $5 | Hold | Maintains | $40 → $5 | +0.60% | Feb 24, 2025 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades n/a | Sell → Hold | Upgrades | n/a | n/a | Feb 24, 2025 |
| Barclays | Barclays | Buy Maintains $2 → $40 | Buy | Maintains | $2 → $40 | +704.83% | Dec 31, 2024 |
| RBC Capital | RBC Capital | Hold Reiterates $80 | Hold | Reiterates | $80 | +1,509.66% | Nov 15, 2024 |
Financial Forecast
Revenue This Year
266.99M
from 83.81M
Increased by 218.58%
Revenue Next Year
265.57M
from 266.99M
Decreased by -0.53%
EPS This Year
-10.05
from -24.84
EPS Next Year
-9.18
from -10.05
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 403.0M | 296.1M | 445.7M | ||
| Avg | 267.0M | 265.6M | 357.8M | ||
| Low | 147.1M | 220.5M | 271.5M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 380.9% | 10.9% | 67.8% | ||
| Avg | 218.6% | -0.5% | 34.7% | ||
| Low | 75.5% | -17.4% | 2.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.68 | -4.20 | -0.93 | ||
| Avg | -10.05 | -9.18 | -4.81 | ||
| Low | -23.13 | -17.64 | -10.00 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.